Springer Nature

Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer

Posted on 2019-01-30 - 05:00
Abstract Objectives To apply a systems pathology-based approach to the quantification of nuclear Active β-catenin and human leukocyte antigen class I, and assess the biomarker involvement in a cohort of prostate tumor patients. Results The systems pathology approach applied allows a precise quantification of the marker expression in the different cell compartments as well as the determination of the areas that coexpress two markers. Our data shows that the accumulation of β-catenin in the nuclear compartment is significantly decreased in the adjacent normal areas when compared to tumor of the same patients (p < 0.001). In conclusion, the application of this novel multiple immunofluorescence assay demonstrates that the upregulation of Active β-catenin is a relatively common feature of prostate tumor development, and further supports the activation of the Wnt/β-catenin pathway in prostate cancer progression.


3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
AAPG Bulletin
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Select your citation style and then place your mouse over the citation text to select it.



Usage metrics

BMC Research Notes


Pere Puig
Nadina Erill
Marta Terricabras
Isaac Subirana
Judit González-García
Adrià Asensi-Puig
Michael Donovan
Lourdes Mengual
M. Agulló-Ortuño
Mireia Olivan
Antonio Alcaraz
José López-Martín
Inés Torres
José Rodríguez-Peralto
Alfredo Rodríguez-Antolín
Juan Morote
Víctor González-Rumayor
need help?